Strategic Overview

bioMérieux is a global leader in in vitro diagnostics with a comprehensive TB testing portfolio including host-response assays.

Innovation Portfolio

ISIT-TB
Category: MONITORING Stage: Late Stage

Blood-based host-response biomarker panel for monitoring TB treatment response. Designed for district laboratory use to support treatment monitoring and outcome prediction.

Host-Response Blood

Key Milestones

ISIT-TB host-response test for TB treatment monitoring
2-hour turnaround
District-level capability
Late-stage development
Global diagnostics leader